Net Income (TTM) Chart

View Net Income (TTM) for AVTR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (TTM) Chart
Start Trial

Historical Net Income (TTM) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -578.00M
March 31, 2026 -551.40M
December 31, 2025 -530.20M
September 30, 2025 -82.20M
June 30, 2025 687.40M
March 31, 2025 715.60M
December 31, 2024 711.50M
September 30, 2024 309.60M
June 30, 2024 360.20M
March 31, 2024 260.00M
December 31, 2023 321.10M
September 30, 2023 364.30M
June 30, 2023 422.90M
March 31, 2023 617.60M
December 31, 2022 686.50M
September 30, 2022 638.80M
Date Value
June 30, 2022 628.60M
March 31, 2022 599.00M
December 31, 2021 572.60M
September 30, 2021 530.20M
June 30, 2021 331.20M
March 31, 2021 233.60M
December 31, 2020 116.60M
September 30, 2020 135.60M
June 30, 2020 199.90M
March 31, 2020 91.00M
December 31, 2019 37.80M
September 30, 2019 -86.10M
June 30, 2019 -73.70M
March 31, 2019 -51.90M
December 31, 2018 -86.90M
September 30, 2018 -159.00M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (TTM) Range, Past 5 Years

View Net Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (TTM) Benchmarks

View Net Income (TTM) Benchmarks
Start Trial
Medpace Holdings, Inc. 491.50M
Champions Oncology, Inc. -1.175M
Personalis, Inc. -107.18M
Adaptive Biotechnologies Corp. -63.99M
10X Genomics, Inc. -75.12M